Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Reipert BM et al. | 1996 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2–65 µT |
Dees C et al. | 1996 | intact cell/cell culture, MCF-7 and T-47D cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz, co-exposure | 1.2–900 µT |
Brisdelli F et al. | 2014 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, co-exposure | 0.01–2 mT |
Cridland NA et al. | 1999 | intact cell/cell culture, HF-19 cells (human fetal lung fibroblasts) | magnetic field, 50/60 Hz | 20 µT–20 mT |
Mannerling AC et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, low frequency, 50/60 Hz | 0.025–0.1 mT |
Saalman E et al. | 1991 | intact cell/cell culture, V79 (Chinese hamster fibroblast cells) | magnetic field, 50/60 Hz | 30 µT |
Marron MT et al. | 1975 | intact cell/cell culture, slime mold microplasmodia and macroplasmodia (<i>Physarum polycephalum</i>) | electric field, magnetic field, low frequency, 50/60 Hz | 40–200 µT |
Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 60 µT |
Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | 60 µT |
Martinez MA et al. | 2016 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.